Unlikely role of Epstein-Barr virus in the pathogenesis of primary cutaneous CD30+ anaplastic large cell lymphoma

European Journal of Dermatology

Volumn 11, Issue 3, 2001, Pages 203-208

  Hellier, Isabelle ^a   Dereure, Olivier ^a   Segondy, Michael ^a   Guillot, Bernard ^a   Baldet, Pierre ^a   Guilhou, Jean Jacques ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

Anaplastic large cell lymphoma; CD30; Epstein Barr virus

Indexed keywords

CD30 ANTIGEN; NUCLEIC ACID; VIRUS DNA; VIRUS PROTEIN; VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; MALE; MULTICENTER STUDY; PATHOGENESIS; POLYMERASE CHAIN REACTION; SKIN DEFECT; SKIN LYMPHOMA;

ADULT; AGED; BIOPSY; CARRIER PROTEINS; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOMA, LARGE-CELL, KI-1; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, VIRAL; SKIN NEOPLASMS;

EID: 0034999871     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. 1. Schwab U, Stein H, Gerdes J, Lemke H, Kirchner H, Schaadt M, Diehl V. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982; 299: 65-7.
2. 2. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848-58.
3. 3. Suchi T, Lennert K, Tu LY, Kikuchi M, Sato E, Stansfeld AG, Feller AC. Histopathology and immunochemistry of peripheral T cell lymphomas: a proposal for their classification. J Clin Pathol 1987; 40: 995-1015.
4. 4. Willemze R, Beljaards RC. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders: a proposal for classification and guideliness for management and treatment. J Am Acad Dermatol 1993; 28: 973-80.
5. 5. Falini B, Pileri S, Pizzolo G, Dürkop H, Flenghi L, Stirpe F, Martelli MF, Stein H. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1995; 85: 1-14.
6. 6. Banerjee SS, Heald J, Harris M. Twelve cases of Ki-1 positive anaplastic lymphoma of skin. J Clin Pathol 1991; 44: 119-25.
7. 7. Kadin ME, Sako D, Berliner N, Franklin W, Woda B, Borowitz M, Ireland K, Schwed A, Herzog P, Lange B, Dorfman R. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood 1986; 5: 1042-9.
8. + cutaneous lymphomas. Curr Probl Dermatol 1990; 19: 132-43.
9. + (CD30) anaplastic large cell lymphomas. Am J Pathol 1989; 135: 359-67.
10. 10. Kaudewitz P, Burg G, Stein H. Ki-1 (CD30) positive cutaneous anaplastic large cell lymphomas. Curr Probl Dermatol 1990; 19: 150-6.
11. 11. Stansfeld AG, Diebold J, Kapanci Y, Kelenyi G, Lennert K, Mioduszewska O, Noel H, Rilke F, Sundstrom C, van Unnik J, Wricht D. Updated Kiel classification for lymphomas. Lancet 1988; 1: 292-3.
12. 12. Beljaards RC, Kaudewitz P, Berti E, Gianotti R, Neumann C, Rosso R, Paulli M, Meijer CJLM, Willemze R. Primary cutaneous CD30-positive large-cell lympnoma: definition of a new type of cutaneous lymphoma with a favorable prognosis: a European multicenter study of 47 patients. Cancer 1993; 71: 2097-104.
13. 13. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Woolf-Peters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke R. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994; 84: 1361-92.
14. 14. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Peréz JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJLM. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma group of the European organization For research and treatment of cancer. Blood 1997; 90: 354-71.
15. 15. Slater D, Epstein-Barr virus: an aetiological factor in lymphoproliferative disorders. J Pathol 1991; 165: 1-4.
16. 16. Weiss LM, Movahed LA, Warnke RA, Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 1989; 320: 502-6.
17. 17. Weiss LM, Chen YY, Liu XF, Shibata D. Epstein-Barr virus and Hodgkin's disease: a correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 1991; 139: 1259-65.
18. 18. Wright CF, Reid AH, Tsai MM, Ventre KM, Murari PJ, Frizzera G, O'Leary TJ. Detection of Epstein-Barr virus sequences in Hodgkin's disease by the polymerase chain reaction. Am J Pathol 1991; 139: 393-8.
19. 19. Kaudewitz P, Burg G. Lymphomatoid papulosis and Ki-1 (CD30)-positive cutaneous large cell lymphomas. Semin Diag Pathol 1991; 8: 117-24.
20. 20. Volkenandt M, Bertino JR, Shenoy BV, Kloch OM, Kadin ME. Molecular evidence for a clonal relationship between lymphomatoid papulosis and Ki-1-positive large cell anaplastic lymphoma. J Dermatol Sci 1993; 6: 121-6.
21. 21. Anagnostopoulos I. Herbst H, Niedobitek G, Stein H. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined southern blot and in situ hybridization. Blood 1989; 74: 810-6.
22. 22. Herbst H, Dallenbach F, Hummel M, Niedobitek G, Finn T, Young LS, Rowe M, Müller-Lantzsch N, Stein H, Epstein-Barr virus DMA latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas. Blood 1991; 78: 2666-73.
23. + malignant lymphomas. Crit Rev Oncongen 1993; 4: 191-239.
24. 24. Kanavaros P, Jiwa NM, De Bruin PC, van der Valk P, Noorduyn LA, Van Heerde P, Gordijn R, Horstman A, Mullink R, Willemze R, Walboomers JMM, Meijer CJLM. High incidence of EBV genome in CD30 positive non-Hodgkin's lymphomas. J Pathol 1992; 168: 307-15.
25. +). Br J Dermatol 1995; 133: 542-6.
26. 26. Borish B, Gatter KC, Tobler A, Theilkäs L, Bunch C, Wainscoat JS, Fey MF. Epstein-Barr virus-associated anaplastic large cell lymphoma in renal transplant patients. Am J Clin Pathol 1992; 98: 312-8.
27. + lymphomas. Am J Clin Pathol 1993; 99: 289-97.
28. 28. Van Gorp J, Doornewaard H, Verdonck LF, Klöpping C, Vos PF, van den Tweel JG. Posttransplant T cell lymphoma. Report of three cases and a review of the literature. Cancer 1994; 73: 3064-72.
29. 29. Anagnostopoulos I, Hummel M, Kaudewitz P, Korbjuhn P, Leoncini L, Stein H. Low incidence of Epstein-Barr virus presence in cutaneous T cell lymphoproliferations. Br J Dermatol 1996; 134: 276-81.
30. 30. De Bruin PC, Jiwa M, Joost JO, Van der Volk P, Sabourin JC, Csanaky G, Gaulard P, Noorduyn AL, Willemze R, Meijer CJLM. Presence of Epstein-Barr virus in extranodal T cell lymphomas: differences in relation to site. Blood 1994; 83: 1612-8.
31. 31. Pabst H, Sander C, Tronnier M, Katzner H, Hugel H, Kandewitz P. Absence of anaplastic lymphoma kinase (ALK) and Epstein-Barr virus gene products in primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis. Br J Dermatol 1997; 137: 680-6.
32. 32. Iwatsuki K, Ohtsuka M, Harada H, Han G, Kaneko F. Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders. Arch Dermatol 1997; 1081-6.
33. +) lymphoma associated with Epstein-Barr virus. Am J Surg Pathol 1992; 16: 796-801.
34. 34. Su Ih-Jen, Tsai TF, Cheng AL, Chen CC. Cutaneous manifestations of Epstein-Barr virus associated T cell lymphoma. J Am Acad Dermatol 1993; 29: 685-92.
35. 35. Ross CW, Schlegelmilch JA, Grogan TM, Weiss LM, Schnitzer B, Hanson CA. Detection or Epstein-Barr virus genome in Ki-1 (CD30)-positive, large-cell anaplastic lymphomas using the polymerase chain reaction. Am J Pathol 1992; 141: 457-65.
36. 36. Beylot-Barry M, Lamant L, Vergier B, de Muret A, Fraitag S, Delord B, Dubus P, Vaillant L, Delaunay M, Mac Grogan G, Beylot C, de Mascarel A, Delsol G, Merlio JP. Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in sifu hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis. Am J Pathol 1996; 149: 483-92.
37. 37. Lopategui JR, Gaffey MJ, Chan JKC, Frierson HF, Sun LH, Bellafiore FJ, Chang KL, Weiss LM. Infrequent association of Epstein-Barr virus with CD30-positive anaplastic large cell lymphomas from American and Asian patients. Am J Surg Pathol 1995; 19: 42-9.
38. 38. Park CK, Ko YH, Detection of EBER nuclear RNA in T cell lymphomas involving the skin: an in situ hybridizotion study. Br J Dermatol 1996; 134: 488-93.
39. 39. Kadin ME. Lymphomatoid papulosis and associated lymphomas. Arch Dermatol 1993; 129: 351-3.
40. 40. Kadin ME, Vonderheid EC, Weiss LM. Absence of Epstein-Barr viral RNA in lymphomatoid papulosis. J Pathol 1993; 170: 145-8.
41. 41. Sangueza OP, Galloway J, Eagan PA, Braziel RM, Gulley ML. Absence of Epstein-Barr virus in lymphomatoid papulosis: an immunohistochemical and in situ hybridization study. Arch Dermatol 1996; 132: 279-82.
42. 42. Anagnostopoulos I, Hummel M, Kaudewitz P, Herbst H, Braun-Falco O, Stein H. Detection of HTLV-1 proviral sequences in CD30 positive large cell cutaneous T cell lymphomas. Am J Pathol 1990; 137: 1317-22.
43. 43. Bitter MA, Franklin WA, Larson RA, McKeithan TW, Rubin CM, Le Beau M, Stephens JK, Vardiman JW. Morphology in Ki-1 (CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol 1990; 14: 305-16.
44. 44. Downing JR, Shurtleff SA, Zielenska M, Curcio-Brint AM, Behm FG, Head DR, Sandlund JT, Weisenburger DD, Kossakowska AE, Thorner P, Lorenzana A, Ladanyi M, Morris SW. Molecular detection of the t(2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood 1995; 12 3416-22.
45. 45. Kaneko Y, Frizzera G, Edamura S, Maseki N, Sakurai M, Komada Y, Sakurai M, Tanaka H Sasaki M, Suchi T, Kikuta A, Wakasa H, Hojo H, Mizutani S. A novel translocation t(2;5)(p23;q35), in childhood phagocytic large T cell lymphoma mimicking malignant histiocytasis. Blood 1989; 3: 806-13.
46. 46. Mason DY, Bastard C, Rimokh R, Dastugue N, Huret JL, Kristoffersson U, Magaud JP, Nezelof C, Vannier JP, Hemet J, Warnke R. CD30-positive large cell lymphomas (Ki-1 lymphoma) are associated with a chromosomal translocation involving 5q35. Br J Haematol 1990; 74: 161-8.
47. 47. Lamant L, Meggetto F, Al Saati T, Brugières L, Bressac de Paillerets B, Dastugue N Bernheim A, Rubie H, Terrier-Lacombe MJ, Robert A, Brousset P, Rigal F, Schlaifer D, Shiota M, Mori S, Delsol G. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and p80 immunostaining. Blood 1996; 87: 284-91.
48. + lymphomas from American and Asian patients. Am J Pathol 1995; 146: 323-8.
49. 49. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994; 263: 1281-4.
50. 50. Falini F, Pulford K, Pucciari A, Carbone A, De Wolf-Peeters C, Cordell J, Fizzotti M, Santucci A, Pelicci PG, Pileri S, Campo E, Ott G, Delsol G, Mason DY. Lymphoma expressing ALK fusion protein(s) other than NPM-ALK. Blood 1999; 94: 3509-15.
51. 51. Hernandez L, Pinyol M, Hernandez S, Dea S, Pilford K, Rosenwald A, Lamant L, Falini F, Ott G, Mason DY, Delsol G, Campo E. TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphomas producing two structurally different TGF-ALK translocations. Blood 1999; 94: 3265-8.
52. + lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood 1996; 87: 3437-41.
53. 53. Schiemann WP, Pfeifer WM, Levi E, Kadin ME, Lodish HF. A deletion in the gene for transforming growth factor beta type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous T cell lymphoma. Blood 1999; 94: 2854-61.